Trial record 1 of 58 for: "Aspergillosis" | "Cytochrome P-450 CYP3A Inhibitors"
Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00620074|
Recruitment Status : Terminated (See Detailed Description)
First Posted : February 21, 2008
Results First Posted : February 15, 2010
Last Update Posted : February 15, 2010
Information provided by:
|Study Design||Allocation: Non-Randomized; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
|Pre-assignment Details||Study was closed due to an overall low rate of enrollment after only 6 subjects enrolled.|
Due to low enrollment and early termination of the study, data was insufficient for descriptive or inferential analysis as planned; no significant treatment-related safety results were identified in the subjects treated with combination therapy.